CVS Health EBIT Margin 2010-2023 | CVS
Current and historical EBIT (Earnings Before Interest & Taxes) margin for CVS Health (CVS) over the last 10 years. The current EBIT profit margin for CVS Health as of December 31, 2023 is .
CVS Health EBIT Margin Historical Data |
Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
2023-12-31 |
$357.78B |
$13.74B |
3.84% |
2023-09-30 |
$347.81B |
$14.03B |
4.03% |
2023-06-30 |
$339.20B |
$6.42B |
1.89% |
2023-03-31 |
$330.92B |
$7.86B |
2.37% |
2022-12-31 |
$322.47B |
$7.95B |
2.47% |
2022-09-30 |
$315.23B |
$6.64B |
2.11% |
2022-06-30 |
$307.86B |
$13.62B |
4.42% |
2022-03-31 |
$299.84B |
$13.28B |
4.43% |
2021-12-31 |
$292.11B |
$13.31B |
4.56% |
2021-09-30 |
$285.06B |
$13.49B |
4.73% |
2021-06-30 |
$278.32B |
$13.68B |
4.91% |
2021-03-31 |
$271.05B |
$14.03B |
5.18% |
2020-12-31 |
$268.71B |
$13.91B |
5.18% |
2020-09-30 |
$266.04B |
$14.42B |
5.42% |
2020-06-30 |
$263.80B |
$14.10B |
5.35% |
2020-03-31 |
$261.89B |
$12.76B |
4.87% |
2019-12-31 |
$256.78B |
$11.99B |
4.67% |
2019-09-30 |
$244.31B |
$9.77B |
4.00% |
2019-06-30 |
$226.99B |
$9.42B |
4.15% |
2019-03-31 |
$210.48B |
$4.72B |
2.24% |
2018-12-31 |
$194.58B |
$4.02B |
2.07% |
2018-09-30 |
$188.56B |
$6.33B |
3.35% |
2018-06-30 |
$187.25B |
$6.25B |
3.34% |
2018-03-31 |
$186.02B |
$9.74B |
5.24% |
2017-12-31 |
$184.79B |
$9.54B |
5.16% |
2017-09-30 |
$182.37B |
$9.43B |
5.17% |
2017-06-30 |
$180.81B |
$9.75B |
5.39% |
2017-03-31 |
$178.85B |
$9.99B |
5.59% |
2016-12-31 |
$177.55B |
$10.39B |
5.85% |
2016-09-30 |
$172.70B |
$10.12B |
5.86% |
2016-06-30 |
$166.73B |
$9.62B |
5.77% |
2016-03-31 |
$160.17B |
$9.53B |
5.95% |
2015-12-31 |
$153.29B |
$9.48B |
6.18% |
2015-09-30 |
$149.20B |
$9.05B |
6.06% |
2015-06-30 |
$145.58B |
$8.96B |
6.16% |
2015-03-31 |
$143.01B |
$8.91B |
6.23% |
2014-12-31 |
$139.37B |
$8.80B |
6.31% |
2014-09-30 |
$135.14B |
$8.70B |
6.43% |
2014-06-30 |
$132.05B |
$8.60B |
6.51% |
2014-03-31 |
$128.70B |
$8.37B |
6.50% |
2013-12-31 |
$126.76B |
$8.04B |
6.34% |
2013-09-30 |
$125.31B |
$8.10B |
6.47% |
2013-06-30 |
$123.61B |
$7.76B |
6.28% |
2013-03-31 |
$123.07B |
$7.50B |
6.09% |
2012-12-31 |
$123.12B |
$7.21B |
5.86% |
2012-09-30 |
$120.04B |
$6.88B |
5.73% |
2012-06-30 |
$116.48B |
$6.65B |
5.71% |
2012-03-31 |
$112.18B |
$6.43B |
5.73% |
2011-12-31 |
$107.08B |
$6.33B |
5.91% |
2011-09-30 |
$103.08B |
$6.12B |
5.94% |
2011-06-30 |
$100.12B |
$6.02B |
6.01% |
2011-03-31 |
$97.71B |
$6.03B |
6.17% |
2010-12-31 |
$95.78B |
$6.14B |
6.41% |
2010-09-30 |
$96.79B |
$6.27B |
6.48% |
2010-06-30 |
$97.72B |
$6.36B |
6.51% |
2010-03-31 |
$98.58B |
$6.46B |
6.55% |
2009-12-31 |
$98.22B |
$6.43B |
6.54% |
Sector |
Industry |
Market Cap |
Revenue |
Retail/Wholesale |
Retail - Drug Stores |
$87.767B |
$357.776B |
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
|